Yukihiro Sanada1, Koichi Mizuta2, Taizen Urahashi2, Yoshiyuki Ihara2, Taiichi Wakiya2, Noriki Okada2, Naoya Yamada2, Kentaro Ushijima3, Shinya Otomo4, Koichi Sakamoto4, Yoshikazu Yasuda5. 1. Department of Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke City, Tochigi, 329-0498, Japan. yuki371@jichi.ac.jp. 2. Department of Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke City, Tochigi, 329-0498, Japan. 3. Department of Clinical Pharmacology, Jichi Medical University, Shimotsuke City, Tochigi, Japan. 4. Department of Pharmacy, Jichi Medical University Hospital, Shimotsuke City, Tochigi, Japan. 5. Department of Surgery, Jichi Medical University, Shimotsuke City, Tochigi, Japan.
Abstract
BACKGROUND: Endotoxin (Et) in the portal vein blood is processed by the hepatic reticuloendothelial system, and therefore, it is possible that the hepatic clearance of Et may become a biological index for liver function. In this study, Et levels of preoperative peripheral and portal vein blood at the time of liver transplantation (LT) were measured in order to study the meaning. METHODS: The study population comprised 19 patients in whom pediatric living donor LT was performed. In the preoperative peripheral and the portal vein blood at the time of LT, we measured Et activity (EA) by the Et activity assay (EAA) and the Limulus amebocyte lysate (LAL) method. RESULTS: The preoperative peripheral vein blood showed a low EA in all cases. In the EA of the peripheral and the portal vein blood, the latter showed a significantly high level (p = 0.049). With the LAL method, 5.3% (2/38) of patients were positive for Et. CONCLUSIONS: The EAA is considered to be superior to the LAL method for the detection of Et, even in low endotoxinemia, and is also capable of elucidating the Et kinetics by accurately reflecting hepatic clearance.
BACKGROUND: Endotoxin (Et) in the portal vein blood is processed by the hepatic reticuloendothelial system, and therefore, it is possible that the hepatic clearance of Et may become a biological index for liver function. In this study, Et levels of preoperative peripheral and portal vein blood at the time of liver transplantation (LT) were measured in order to study the meaning. METHODS: The study population comprised 19 patients in whom pediatric living donor LT was performed. In the preoperative peripheral and the portal vein blood at the time of LT, we measured Et activity (EA) by the Et activity assay (EAA) and the Limulus amebocyte lysate (LAL) method. RESULTS: The preoperative peripheral vein blood showed a low EA in all cases. In the EA of the peripheral and the portal vein blood, the latter showed a significantly high level (p = 0.049). With the LAL method, 5.3% (2/38) of patients were positive for Et. CONCLUSIONS: The EAA is considered to be superior to the LAL method for the detection of Et, even in low endotoxinemia, and is also capable of elucidating the Et kinetics by accurately reflecting hepatic clearance.
Authors: John C Marshall; Debra Foster; Jean-Louis Vincent; Deborah J Cook; Jonathan Cohen; R Phillip Dellinger; Steven Opal; Edward Abraham; Stephen J Brett; Terry Smith; Sangeeta Mehta; Anastasia Derzko; Alex Romaschin Journal: J Infect Dis Date: 2004-07-02 Impact factor: 5.226
Authors: C C Chan; S J Hwang; F Y Lee; S S Wang; F Y Chang; C P Li; C J Chu; R H Lu; S D Lee Journal: Scand J Gastroenterol Date: 1997-09 Impact factor: 2.423
Authors: D W Bates; J Parsonnet; P A Ketchum; E B Miller; T J Novitsky; K Sands; P L Hibberd; P S Graman; P N Lanken; J S Schwartz; K Kahn; D R Snydman; R Moore; E Black; R Platt Journal: Clin Infect Dis Date: 1998-09 Impact factor: 9.079
Authors: A D Romaschin; D M Harris; M B Ribeiro; J Paice; D M Foster; P M Walker; J C Marshall Journal: J Immunol Methods Date: 1998-03-15 Impact factor: 2.303
Authors: John C Marshall; Paul M Walker; Debra M Foster; David Harris; Melanie Ribeiro; Jeff Paice; Alexander D Romaschin; Anastasia N Derzko Journal: Crit Care Date: 2002-05-02 Impact factor: 9.097